Ignite Creation Date:
2024-05-05 @ 10:03 PM
Last Modification Date:
2024-10-26 @ 10:13 AM
Study NCT ID:
NCT01017653
Status:
TERMINATED
Last Update Posted:
2013-09-04
First Post:
2009-11-19
Brief Title:
Panitumumab and Irinotecan for Malignant Gliomas
Sponsor:
Annick Desjardins
Organization:
Duke University
Organization Data
Organization:
Duke University
Class:
OTHER
Study ID:
Pro00015447
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Annick Desjardins
Lead Sponsor Class:
OTHER
Responsible Party:
Annick Desjardins
Responsible Party Title:
Assist Professor of Medicine-Neurology
Responsible Party Type:
SPONSOR_INVESTIGATOR
Responsible Party Affiliation:
Duke University
Old Name:
None
Old Organization:
None
Collaborators
| Name | Class |
|---|---|
| Amgen | INDUSTRY |